Tumors of female reproductive systemTumors of female reproductive systemОпухоли женской репродуктивной системы1994-40981999-8627Publishing House ABV Press13310.17650/1994-4098-2012-0-3-4-165-168GYNECOLOGY. TREATMENTГИНЕКОЛОГИЯ. ЛЕЧЕНИЕSerous borderline ovarian tumors (clinical features, morphology, treatment)Серозные пограничные опухоли яичников (клиническое течение, морфология, лечение)DavydovaI. Yu.ДавыдоваИ. Ю.
Russian Federation
davydova06@mail.ruKuznetsovV. V.КузнецовВ. В.
Russian Federation
KarseladzeA. I.КарселадзеА. И.
Russian Federation
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowФГБУ «РОНЦ им. Н.Н. Блохина» РАМН, Москва240920123-416516824072014240720142012https://ojrs.abvpress.ru/ojrs/article/view/133

This article considers the clinical features, morphology and general conteporary principles of treatment of ovarian serous borderline tumors. Despite to presence of several malignant signs in borderline ovarian tumors, disease rather has favorable outcome. It allows to perform the conservative surgery for patient in reproductive age, preserve ovarian tissue and save fertility.

В статье рассматривается вопрос об особенностях клинического течения, морфологии и современных принципов лечения серозных пограничных опухолей яичников (ПОЯ). Несмотря на присутствие в пограничных опухолях некоторых признаков злокачественности, течение заболевания относительно благоприятное. Это позволяет выполнять консервативные операции с сохранением ткани яичника пациенткам репродуктивного возраста. Подобная тактика широко применяется в мире и позволяет больным с ПОЯ сохранять фертильность.

borderline ovarian tumorsserous ovarian tumorsatypical proliferative tumorsovarian low malignant potential tumorsпограничные опухоли яичниковсерозные опухоли яичниковатипически пролиферирующие опухолиопухоли яичников с низким потенциалом злокачественности1. Longacre T.A., Kempson R.L., Hendrickson M.R. Well differentiated serous neoplasms of the ovary. In: Hendrickson M.R. (ed.) Surface Epithelial Neoplasms of the Ovary. Philadelphia: Hanley and Belfus, 1993:255−306.Longacre T.A., Kempson R.L., Hendrickson M.R. Well differentiated serous neoplasms of the ovary. In: Hendrickson M.R. (ed.) Surface Epithelial Neoplasms of the Ovary. Philadelphia: Hanley and Belfus, 1993:255−306.2. Seidman J.D., Kurman R.J. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539−57.Seidman J.D., Kurman R.J. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539−57.3. McKenney J.K., Balzer B.L., Longacre T.A. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am J Surg Pathol 2006; 30:614−24.McKenney J.K., Balzer B.L., Longacre T.A. Lymph node involvement in ovarian serous tumors of low malignant potential (borderline tumors): pathology, prognosis, and proposed classification. Am J Surg Pathol 2006; 30:614−24.4. Slomovitz B.M., Caputo T.A., Gretz H.F. 3rd et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002;26:592−600.Slomovitz B.M., Caputo T.A., Gretz H.F. 3rd et al. A comparative analysis of 57 serous borderline tumors with and without a noninvasive micropapillary component. Am J Surg Pathol 2002;26:592−600.5. Bell D.A., Longacre T.A., Prat J. et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors workshop perspectives. Hum Pathol 2004;35:934−48.Bell D.A., Longacre T.A., Prat J. et al. Serous borderline (low malignant potential, atypical proliferative) ovarian tumors workshop perspectives. Hum Pathol 2004;35:934−48.6. Bell D.A., Scully R.E. Ovarian serous border- line tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397−403.Bell D.A., Scully R.E. Ovarian serous border- line tumors with stromal microinvasion: a report of 21 cases. Hum Pathol 1990;21:397−403.7. Burks R.T., Sherman M.E., Kurman R.J. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20:1319−30.Burks R.T., Sherman M.E., Kurman R.J. Micropapillary serous carcinoma of the ovary. A distinctive low-grade carcinoma related to serous borderline tumors. Am J Surg Pathol 1996;20:1319−30.8. Eichhorn J.H., Bell D.A., Young R.H. et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;23:397−409.Eichhorn J.H., Bell D.A., Young R.H. et al. Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol 1999;23:397−409.9. Prat J., De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micro- papillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111−28.Prat J., De Nictolis M. Serous borderline tumors of the ovary: a long-term follow-up study of 137 cases, including 18 with a micro- papillary pattern and 20 with microinvasion. Am J Surg Pathol 2002;26:1111−28.10. Singer G., Oldt R. 3rd, Cohen Y. et al. Mutations in BRAF and KRAS characterizeSinger G., Oldt R. 3rd, Cohen Y. et al. Mutations in BRAF and KRAS characterizethe development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 2003;95:484−6.11. Gilks C.B., Alkushi A., Yue J.J. et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol 2003;22:29−36.Gilks C.B., Alkushi A., Yue J.J. et al. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases. Int J Gynecol Pathol 2003;22:29−36.12. Rollins S.E., Young R.H., Bell D.A. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol 2006;30:457−62.Rollins S.E., Young R.H., Bell D.A. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma. Am J Surg Pathol 2006;30:457−62.13. Staging Classifications and Clinical Practice Guidelines for Gynaecologic Cancers FIGO Committee on Gynaecologic Oncology, 2006. http://www.rho.org/files/FIGO_ Clinical_practice_guidelines_2000.pdfStaging Classifications and Clinical Practice Guidelines for Gynaecologic Cancers FIGO Committee on Gynaecologic Oncology, 2006. http://www.rho.org/files/FIGO_ Clinical_practice_guidelines_2000.pdf14. Longacre T.A., McKenney J.K, Tazelaar H.D. et al. Ovarian serous tumors of low malignant potential (borderline tumors). Outcome-based study of 276 patients with long-term ( 5-year) follow-up. Am J Surg Pathol 2005;29:707−23.Longacre T.A., McKenney J.K, Tazelaar H.D. et al. Ovarian serous tumors of low malignant potential (borderline tumors). Outcome-based study of 276 patients with long-term ( 5-year) follow-up. Am J Surg Pathol 2005;29:707−23.